Back to Trades
Grant4
Anika Therapeutics, Inc.
ANIK
Total Value
$381.0K
Company Information
- Company Name
- Anika Therapeutics, Inc.
- Ticker Symbol
- ANIK
- CIK
- 0000898437
Insider Information
- Role
- Insider
- Location
- BEDFORD, MA
Filing Details
- Filing Date
- Mar 17, 2026
- Transaction Date
- Mar 14, 2026
- Accession Number
- 0001193125-26-111494
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 14, 2026 | Common Stock | 24,519 | — | Exercise | — |
| Mar 14, 2026 | Common Stock | 24,520 | — | Grant/Award | — |
| Mar 14, 2026 | Common Stock | 14,728 | $14.20 | Tax Withholding | $209.1K |
| Mar 15, 2026 | Common Stock | 25,131 | — | Exercise | — |
| Mar 15, 2026 | Common Stock | 12,104 | $14.20 | Tax Withholding | $171.9K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 14, 2026 | Derivative | 24,519 | — | Exercise | — |
| Mar 15, 2026 | Derivative | 25,131 | — | Exercise | — |
Footnotes
- (F1)Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
- (F2)On March 14, 2025, the Reporting Person was granted 73,559 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.
- (F3)Reflects an aggregate of 14,728 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.
- (F4)Reflects an aggregate of 12,104 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026.
- (F5)Consists of shares held by The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which the Reporting Person is a beneficiary and the sole trustee.
- (F6)On March 14, 2025, the Reporting Person was granted 73,559 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.
- (F7)On March 15, 2024, the Reporting Person was granted 75,395 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.